1. Home
  2. CTKB vs HIVE Comparison

CTKB vs HIVE Comparison

Compare CTKB & HIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • HIVE
  • Stock Information
  • Founded
  • CTKB 1990
  • HIVE 1987
  • Country
  • CTKB United States
  • HIVE United States
  • Employees
  • CTKB N/A
  • HIVE N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HIVE
  • Sector
  • CTKB Health Care
  • HIVE
  • Exchange
  • CTKB Nasdaq
  • HIVE Nasdaq
  • Market Cap
  • CTKB 526.7M
  • HIVE 459.0M
  • IPO Year
  • CTKB 2021
  • HIVE N/A
  • Fundamental
  • Price
  • CTKB $3.92
  • HIVE $3.88
  • Analyst Decision
  • CTKB Hold
  • HIVE Strong Buy
  • Analyst Count
  • CTKB 4
  • HIVE 6
  • Target Price
  • CTKB $6.00
  • HIVE $6.83
  • AVG Volume (30 Days)
  • CTKB 932.3K
  • HIVE 28.0M
  • Earning Date
  • CTKB 11-04-2025
  • HIVE 11-12-2025
  • Dividend Yield
  • CTKB N/A
  • HIVE N/A
  • EPS Growth
  • CTKB N/A
  • HIVE 42.43
  • EPS
  • CTKB N/A
  • HIVE 0.34
  • Revenue
  • CTKB $196,035,000.00
  • HIVE $128,649,000.00
  • Revenue This Year
  • CTKB $0.09
  • HIVE $190.37
  • Revenue Next Year
  • CTKB $7.45
  • HIVE $41.48
  • P/E Ratio
  • CTKB N/A
  • HIVE $11.32
  • Revenue Growth
  • CTKB N/A
  • HIVE 4.47
  • 52 Week Low
  • CTKB $2.37
  • HIVE $1.26
  • 52 Week High
  • CTKB $7.63
  • HIVE $5.54
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 49.11
  • HIVE 79.46
  • Support Level
  • CTKB $3.80
  • HIVE $3.70
  • Resistance Level
  • CTKB $4.14
  • HIVE $4.33
  • Average True Range (ATR)
  • CTKB 0.21
  • HIVE 0.25
  • MACD
  • CTKB -0.03
  • HIVE 0.11
  • Stochastic Oscillator
  • CTKB 41.24
  • HIVE 74.14

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About HIVE HIVE Digital Technologies Ltd.

HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.

Share on Social Networks: